Amanote Research
Register
Sign In
An Online Four-Dimensional HICSEC-IMMS Methodology for Proof-Of-Concept Characterization of Antibody Drug Conjugates
doi 10.1021/acs.analchem.7b02110.s001
Full Text
Open PDF
Abstract
Available in
full text
Date
Unknown
Authors
Unknown
Publisher
American Chemical Society (ACS)
Related search
The Promise of Antibody–Drug Conjugates
New England Journal of Medicine
Medicine
Antibody-Drug Conjugates for the Therapy of Thoracic Malignancies
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Design and Characterization of Homogenous Antibody-Drug Conjugates With a Drug-To-Antibody Ratio of One Prepared Using an Engineered Antibody and a Dual-Maleimide Pyrrolobenzodiazepine Dimer
mAbs
Allergy
Immunology
Site-Specific Antibody Drug Conjugates for Cancer Therapy
mAbs
Allergy
Immunology
Preclinical Pharmacokinetic Considerations for the Development of Antibody Drug Conjugates
Pharmaceutical Research
Organic Chemistry
Biotechnology
Molecular Medicine
Pharmacology
Pharmaceutical Science
Antibody-Drug Conjugates in Bladder Cancer
Bladder Cancer
Oncology
Urology
Antibody – Drug Conjugates (ADC) – Drug Discovery Today: Technologies
Drug Discovery Today: Technologies
Biotechnology
Drug Discovery
Molecular Medicine
Studies on Antibody-Anticancer Drug Conjugates
Okayama Igakkai Zasshi (Journal of Okayama Medical Association)
Synthesis and Biological Evaluation of Antibody Drug Conjugates Based on an Antibody Expression System: Conamax
ACS Omega
Chemistry
Chemical Engineering
